Results

Neurocrine Biosciences Inc.

05/05/2019 | Press release | Distributed by Public on 05/05/2019 07:07

Neurocrine Biosciences Presents Phase III Data Analysis Demonstrating that Opicapone Added to Levodopa Resulted in a Significant and Sustained Increase in ON Time without[...]